搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Trinomys iheringi Cytochrome b (MT-CYB), partial CSB-YP654285TAAT
CSB-EP654285TAAT
CSB-BP654285TAAT
CSB-MP654285TAAT
CSB-EP654285TAAT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytochrome b (MT-CYB), partial CSB-YP654286TCK
CSB-EP654286TCK
CSB-BP654286TCK
CSB-MP654286TCK
CSB-EP654286TCK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uroderma bilobatum Cytochrome b (MT-CYB), partial CSB-YP654287UAAB
CSB-EP654287UAAB
CSB-BP654287UAAB
CSB-MP654287UAAB
CSB-EP654287UAAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays NADH-ubiquinone oxidoreductase chain 5 (ND5), partial CSB-YP654288ZAX1
CSB-EP654288ZAX1
CSB-BP654288ZAX1
CSB-MP654288ZAX1
CSB-EP654288ZAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Babyrousa babyrussa Cytochrome b (MT-CYB), partial CSB-YP654289BBAD
CSB-EP654289BBAD
CSB-BP654289BBAD
CSB-MP654289BBAD
CSB-EP654289BBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Locusta migratoria NADH-ubiquinone oxidoreductase chain 2 (ND2), partial CSB-YP654290LHY
CSB-EP654290LHY
CSB-BP654290LHY
CSB-MP654290LHY
CSB-EP654290LHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ornithorhynchus anatinus ATP synthase subunit a (MT-ATP6), partial CSB-YP654291OEX1
CSB-EP654291OEX1
CSB-BP654291OEX1
CSB-MP654291OEX1
CSB-EP654291OEX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ornithorhynchus anatinus Cytochrome b (MT-CYB), partial CSB-YP654292OEX
CSB-EP654292OEX
CSB-BP654292OEX
CSB-MP654292OEX
CSB-EP654292OEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Onychium japonicum Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP654293OAAJ
CSB-EP654293OAAJ
CSB-BP654293OAAJ
CSB-MP654293OAAJ
CSB-EP654293OAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodella violacea C-phycocyanin alpha chain (cpcA) CSB-YP654294RLA
CSB-EP654294RLA
CSB-BP654294RLA
CSB-MP654294RLA
CSB-EP654294RLA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trimorphomyces papilionaceus NADH-ubiquinone oxidoreductase chain 4L (ND4L), partial CSB-YP654295TAAU1
CSB-EP654295TAAU1
CSB-BP654295TAAU1
CSB-MP654295TAAU1
CSB-EP654295TAAU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant ATP-dependent Clp protease proteolytic subunit (clpP-A) CSB-YP654296DZX
CSB-EP654296DZX
CSB-BP654296DZX
CSB-MP654296DZX
CSB-EP654296DZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmo trutta ATP synthase subunit a (mt-atp6), partial CSB-YP654297SWJ1
CSB-EP654297SWJ1
CSB-BP654297SWJ1
CSB-MP654297SWJ1
CSB-EP654297SWJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sciurus aberti Cytochrome b (MT-CYB), partial CSB-YP654298SCAS
CSB-EP654298SCAS
CSB-BP654298SCAS
CSB-MP654298SCAS
CSB-EP654298SCAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oncorhynchus masou NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP654299OEH1
CSB-EP654299OEH1
CSB-BP654299OEH1
CSB-MP654299OEH1
CSB-EP654299OEH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii ATP synthase subunit c, chloroplastic (atpH), partial CSB-YP654300DSJ1
CSB-EP654300DSJ1
CSB-BP654300DSJ1
CSB-MP654300DSJ1
CSB-EP654300DSJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii Cytochrome c oxidase subunit 1+2 (COX1/2), partial CSB-YP654301AAJ
CSB-EP654301AAJ
CSB-BP654301AAJ
CSB-MP654301AAJ
CSB-EP654301AAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii ATP synthase subunit 9, mitochondrial (ATP9), partial CSB-YP654302AAJ1
CSB-EP654302AAJ1
CSB-BP654302AAJ1
CSB-MP654302AAJ1
CSB-EP654302AAJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii NADH-ubiquinone oxidoreductase 49 kDa subunit (NAD7) CSB-YP654303AAJ
CSB-EP654303AAJ
CSB-BP654303AAJ
CSB-MP654303AAJ
CSB-EP654303AAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Goat Cytochrome c oxidase subunit 2 (MT-CO2), partial CSB-YP654304GO1
CSB-EP654304GO1
CSB-BP654304GO1
CSB-MP654304GO1
CSB-EP654304GO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>